SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-01-001092
Filing Date
2001-03-30
Accepted
2001-03-30 00:00:00
Documents
8
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 BIOGEN INC. b38146bge10-k.txt 10-K 97093
2 LETTER AGREEMENT-JAMES L VINCENT b38146bgex10-50.txt EX-10.50 2425
3 LETTER EMPLOYMENT- THOMAS J. BUCKNUM b38146bgex10-56.txt EX-10.56 3710
4 LETTER AGREEMENT-CORNELIS BEEN b38146bgex10-57.txt EX-10.57 9078
5 LETTER AGREEMENT-JAMES C. MULLEN b38146bgex10-58.txt EX-10.58 1422
6 ANNUAL REPORT TO SHAREHOLDERS b38146bgex13.txt EX-13 161091
7 SUBSIDIARIES b38146bgex21.txt EX-21 1493
8 CONSENT OF PRICEWATERHOUSECOOPERS LLP b38146bgex23.txt EX-23 828
  Complete submission text file 0000950135-01-001092.txt   279604
Mailing Address 14 CAMBRIDGE CTR CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CTR CAMBRIDGE MA 02142 6176792000
BIOGEN INC (Filer) CIK: 0000714655 (see all company filings)

IRS No.: 043002117 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12042 | Film No.: 1588475
SIC: 2836 Biological Products, (No Diagnostic Substances)